Cypher Genomics has selected BIOBASE Genome Trax for the whole genome interpretation.
As part of the genome interpretation, Cypher Genomics researchers will incorporate the knowledgebase in Genome Trax to assist in interpretation of next generation sequencing variants to give genomic knowledge from sequencing data.
Cypher Genomics offers automated software solutions for medical geneticists, computational biologists, clinicians and researchers who aim to extract maximal value from whole genome sequencing while Genome Trax interprets next generation-sequencing (NGS) data and converts the genomic data to actionable genomic knowledge.
Genome Trax prioritizes human genome variants in whole genome or exome data and also identifies new mutations, which are likely to affect the function of candidate disease genes thus enabling users to remove millions of irrelevant variants.
Cypher Genomics chief science officer said, "Genome TraxTM provides the most comprehensive database of human disease associations and is an invaluable resource in both clinical and research-grade genetics and genomics activities.''
BIOBASE CTO Frank Schacherer said Cypher Genomics interprets genomes with precision and enables the use of genomics in diagnosis, discovery, and treatment.
''Genome TraxTM frees them to focus on their deep expertise in computer science, quantitative genetics, and medicine, to deliver state-of-the-art genome processing to their customers," Schacherer added.
